CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$111.62
−1.05%Sep 4, 2026, 21:50 UTC
Dow Jones Indices announced changes to the S&P 600 index, adding ten companies and removing ten others, effective before the open on September 21, 2026, as part of the quarterly rebalance.
Source:Sep 4, 2026, 21:18 UTC
S&P Dow Jones Indices announced the inclusion of HubSpot, AGNC, Corcept, and Brinker into the S&P MidCap 400 index.
Source:Jul 31, 2026, 15:34 UTC
Corcept Therapeutics launched LIFYORLI, which generated $47.6 million in its first full quarter.
Source:Jul 29, 2026, 20:05 UTC
Corcept Therapeutics reported its financial results for the second quarter ended June 30, 2026.
Jun 22, 2026, 21:00 UTC
Fred Alger Management, LLC announced the quarterly rebalancing of the Alger Russell Innovation Index, effective after the close of trading on June 26, 2026, with additions and deletions of several companies.
Source:Jun 17, 2026, 20:28 UTC
Corcept Therapeutics resubmitted its New Drug Application to the FDA for relacorilant as a treatment for Cushing's syndrome.
Source: